Literature DB >> 52908

HL-A27 and anterior uveitis.

J C Woodrow, R Mapstone, J Anderson, N Usher.   

Abstract

HL-A types were determined in 90 successive patients with non-granulomatous uveitis. Fifty-one were HL-A27 positive (55.7%) compared to 8.2% of controls. Of 16 patients with ankylosing spondylitis, 13 were HL-A27 positive, as were two patients with a history of Reiter's syndrome. Twenty-eight patients were HL-A27 positive but had no evidence of rheumatic disease. The findings are discussed in relation to the possible pathogenesis of uveitis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52908

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

Review 1.  The HLA linkage group and disease susceptibility.

Authors:  J Bertrams; M Spitznas
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-07-26

2.  Discordance for ankylosing spondylitis in monozygotic twins.

Authors:  C J Eastmond; J C Woodrow
Journal:  Ann Rheum Dis       Date:  1977-08       Impact factor: 19.103

3.  [HLA antigens in uveitis anterior (author's transl)].

Authors:  H F Wenk; K W Ruprecht; F Schunter
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

Review 4.  HLA and eye disease.

Authors:  A H Rahi
Journal:  Br J Ophthalmol       Date:  1979-05       Impact factor: 4.638

5.  Iridocyclitis in black Americans: association with HLA B8 suggests an autoimmune aetiology.

Authors:  R B Nussenblatt; K K Mittal
Journal:  Br J Ophthalmol       Date:  1981-05       Impact factor: 4.638

6.  Aortic incompetence in HLA B27-positive juvenile arthritis.

Authors:  W F Kean; T P Anastassiades; P M Ford
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

7.  HLA antigens and uveitis.

Authors:  S Ohno; S J Kimura; G R O'Connor; D H Char
Journal:  Br J Ophthalmol       Date:  1977-01       Impact factor: 4.638

Review 8.  Seronegative arthropathies.

Authors:  J M Moll
Journal:  J R Soc Med       Date:  1983-06       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.